autologous mesenchymal stem cell transplantation

BIOLOGICAL5 trials

Conditions

CirrhosisLiver CirrhosisProgressive Relapsing Multiple SclerosisRelapsing-Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisType 1 Diabetes MellitusType 1 diabetes. Insulin-dependent diabetes mellitus

Phase 1

Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS

CompletedNCT00813969

The Cleveland ClinicProgressive Relapsing Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Start: 2011-03-31End: 2014-05-31Updated: 2016-03-30

Phase 2

Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis

CompletedNCT00476060

University of TehranCirrhosis

Start: 2007-01-31End: 2011-08-31Updated: 2023-05-16

Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study

TerminatedNCT02057211

Uppsala University HospitalType 1 Diabetes Mellitus

Start: 2014-04-30End: 2017-11-30Updated: 2020-11-06

Unknown Phase

Mesenchymal stem cell transplantation in the treatment of type 1 diabetic patients

Active, not recruitingIRCT138810271414N8

Endocrinology & Metabolism Research CenterType 1 diabetes. Insulin-dependent diabetes mellitus

Start: 2010-01-15Target: 20Updated: 2018-02-22

Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis

NCT01499459

Saglik Bilimleri Universitesi Gulhane Tip FakultesiLiver Cirrhosis

Start: 2008-06-30End: 2012-08-31Target: 25Updated: 2012-03-22

Related Papers

Assessment of immune-alternations and their correlations with therapeutic outcomes of transplantation of autologous Mesenchymal and Allogenic fetal stem cells in patients with type 1 diabetes: a study protocol.